Deutsche Bank Initiates Coverage On Patterson Companies(PDCO). In a research note issued to the investors, the brokerage major Announces the price-target to $45 per share. The shares have been rated Hold. The rating by the stock financial advisor at Deutsche Bank was issued on Mar 15, 2017 in a research report to their Investors and Clients.
In a different note, On Jan 3, 2017, Baird said it Upgrades its rating on Patterson Companies. According to the research note, Baird Raises the price target to $47 per share from a prior target of $38. The shares have been rated ‘Outperform’ by the firm.
Patterson Companies (PDCO) shares turned negative on Fridays trading session with the shares closing down -0.06 points or -0.13% at a volume of 11,29,897. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $45.765. The peak price level was also seen at $45.765 while the days lowest was $45.38. Finally the shares closed at $45.48. The 52-week high of the shares is $50.4 while the 52-week low is $36.46. According to the latest information available, the market cap of the company is $4,418 M.
Patterson Companies(PDCO) last announced its earnings results on Nov 22, 2016 for Fiscal Year 2017 and Q2.Company reported revenue of $1.42B. Analysts had an estimated revenue of $1.44B. Earnings per share were $0.56. The reported EPS was above estimates by $0.04 or NaN%. Analysts had estimated an EPS of $0.60.
Several Insider Transactions has been reported to the SEC. On Mar 10, 2017, James W Wiltz (director) sold 5,000 shares at $44.52 per share price.Also, On Mar 10, 2017, David G Misiak (President, Patterson Dental) sold 301 shares at $45.57 per share price.On Mar 3, 2017, Ellen A Rudnick (director) sold 3,000 shares at $45.70 per share price, according to the Form-4 filing with the securities and exchange commission.
Patterson Companies Inc. is a distributor serving the dental veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply veterinary supply and rehabilitation supply. The Company’s dental supply segment provides consumable products (including x-ray film restorative materials hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems and office forms and stationery. The Company’s veterinary supply segment distributes veterinary supplies to companion-pet (dogs cats and other common household pets) equine and large animal veterinarians and veterinary clinics public and private institutions and shelters across the United States and in the United Kingdom. The rehabilitation supply segment distributes rehabilitation medical supplies and equipment.